| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Radiology, Vol 195, 333-337, Copyright © 1995 by Radiological Society of North America
ARTICLES |
H Ahlstrom, B Eriksson, M Bergstrom, P Bjurling, B Langstrom and K Oberg
Department of Diagnostic Radiology, University Hospital, Uppsala, Sweden.
PURPOSE: To evaluate the use of carbon-11-labeled L- dihydroxyphenylalanine (L-DOPA) and hydroxytryptophan (5-HTP) in the diagnosis of pancreatic endocrine tumors with positron emission tomography (PET). MATERIALS AND METHODS: Twenty-two consecutive patients with clinically and biochemically verified pancreatic endocrine tumors were examined with computed tomography (CT) and PET with L-DOPA alone (n = 16) or both C-11-L-DOPA and C-11-5-HTP (n = 6). RESULTS: Tumor uptake of L-DOPA was found in 11 patients, eight of whom had metastatic disease. Heterogeneity of tracer uptake was noted among different lesions in the same patient (ie, high uptake in some lesions and low uptake in others). Results in patients examined with both L- DOPA and 5-HTP correlated well, but the uptake levels of 5-HTP were higher in two of three patients with positive findings. In two additional patients, CT enabled detection of tumors not detected at PET. CONCLUSION: The current PET technique can be a valuable complement to CT in demonstration of functional pancreatic endocrine tumors, in particular, glucagonomas, but is less useful in detection of nonfunctional tumors.
This article has been cited by other articles:
|
|
 |
|
  S. Kauhanen, M. Seppanen, H. Minn, R. Gullichsen, A. Salonen, K. Alanen, R. Parkkola, O. Solin, J. Bergman, T. Sane, et al. Fluorine-18-L-Dihydroxyphenylalanine (18F-DOPA) Positron Emission Tomography as a Tool to Localize an Insulinoma or {beta}-Cell Hyperplasia in Adult Patients J. Clin. Endocrinol. Metab., April 1, 2007; 92(4): 1237 - 1244. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Montravers, D. Grahek, K. Kerrou, P. Ruszniewski, V. de Beco, N. Aide, F. Gutman, J.-D. Grange, J.-P. Lotz, and J.-N. Talbot Can Fluorodihydroxyphenylalanine PET Replace Somatostatin Receptor Scintigraphy in Patients with Digestive Endocrine Tumors? J. Nucl. Med., September 1, 2006; 47(9): 1455 - 1462. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Otonkoski, K. Nanto-Salonen, M. Seppanen, R. Veijola, H. Huopio, K. Hussain, P. Tapanainen, O. Eskola, R. Parkkola, K. Ekstrom, et al. Noninvasive Diagnosis of Focal Hyperinsulinism of Infancy With [18F]-DOPA Positron Emission Tomography Diabetes, January 1, 2006; 55(1): 13 - 18. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Orlefors, A. Sundin, U. Garske, C. Juhlin, K. Oberg, B. Skogseid, B. Langstrom, M. Bergstrom, and B. Eriksson Whole-Body 11C-5-Hydroxytryptophan Positron Emission Tomography as a Universal Imaging Technique for Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy and Computed Tomography J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3392 - 3400. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-J. Ribeiro, P. De Lonlay, T. Delzescaux, N. Boddaert, F. Jaubert, S. Bourgeois, F. Dolle, C. Nihoul-Fekete, A. Syrota, and F. Brunelle Characterization of Hyperinsulinism in Infancy Assessed with PET and 18F-Fluoro-L-DOPA J. Nucl. Med., April 1, 2005; 46(4): 560 - 566. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Pacak, G. Eisenhofer, and D. S. Goldstein Functional Imaging of Endocrine Tumors: Role of Positron Emission Tomography Endocr. Rev., August 1, 2004; 25(4): 568 - 580. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Becherer, M. Szabo, G. Karanikas, P. Wunderbaldinger, P. Angelberger, M. Raderer, A. Kurtaran, R. Dudczak, and K. Kletter Imaging of Advanced Neuroendocrine Tumors with 18F-FDOPA PET J. Nucl. Med., July 1, 2004; 45(7): 1161 - 1167. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Pacak, I. Ilias, C. C. Chen, J. A. Carrasquillo, M. Whatley, and L. K. Nieman The Role of [18F]Fluorodeoxyglucose Positron Emission Tomography and [111In]-Diethylenetriaminepentaacetate-D-Phe-Pentetreotide Scintigraphy in the Localization of Ectopic Adrenocorticotropin-Secreting Tumors Causing Cushing's Syndrome J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2214 - 2221. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M K Kalra, M M Maher, P R Mueller, and S Saini State-of-the-art imaging of pancreatic neoplasms Br. J. Radiol., December 1, 2003; 76(912): 857 - 865. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. K. Kalra, M. M. Maher, G. W. Boland, S. Saini, and A. J. Fischman Correlation of Positron Emission Tomography and CT in Evaluating Pancreatic Tumors: Technical and Clinical Implications Am. J. Roentgenol., August 1, 2003; 181(2): 387 - 393. [Full Text] [PDF]
|
|
|
|
 |
|
 N Power and R H Reznek Imaging pancreatic islet cell tumours Imaging, April 1, 2002; 14(2): 147 - 159. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Hoegerle, C. Altehoefer, N. Ghanem, G. Koehler, C. F. Waller, H. Scheruebl, E. Moser, and E. Nitzsche Whole-Body 18F Dopa PET for Detection of Gastrolintestinal Carcinoid Tumors Radiology, August 1, 2001; 220(2): 373 - 380. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Dimitrakopoulou-Strauss, L. G. Strauss, and C. Burger Quantitative PET Studies in Pretreated Melanoma Patients: A Comparison of 6-[18F]Fluoro-L-Dopa with 18F-FDG and 15O-Water Using Compartment and Noncompartment Analysis J. Nucl. Med., February 1, 2001; 42(2): 248 - 256. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| RADIOLOGY | RADIOGRAPHICS | RSNA JOURNALS ONLINE |
